• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bcl-2基因可促进造血细胞存活,并与c-myc协同作用使前B细胞永生化。

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.

作者信息

Vaux D L, Cory S, Adams J M

机构信息

Walter and Eliza Hall Institute of Medical Research, PO Royal Melbourne Hospital, Victoria, Australia.

出版信息

Nature. 1988 Sep 29;335(6189):440-2. doi: 10.1038/335440a0.

DOI:10.1038/335440a0
PMID:3262202
Abstract

A common feature of follicular lymphoma, the most prevalent haematological malignancy in humans, is a chromosome translocation (t(14;18] that has coupled the immunoglobulin heavy chain locus to a chromosome 18 gene denoted bcl-2. By analogy with the translocated c-myc oncogene in other B-lymphoid tumours bcl-2 is a candidate oncogene, but no biological effects of bcl-2 have yet been reported. To test whether bcl-2 influences the growth of haematopoietic cells, either alone or together with a deregulated c-myc gene, we have introduced a human bcl-2 complementary DNA using a retroviral vector into bone marrow cells from either normal or E mu-myc transgenic mice, in which B-lineage cells constitutively express the c-myc gene. Bcl-2 cooperated with c-myc to promote proliferation of B-cell precursors, some of which became tumorigenic. To determine how bcl-2 expression impinges on growth factor requirements, the gene was introduced into a lymphoid and a myeloid cell line that require interleukin 3 (IL-3). In the absence of IL-3, bcl-2 promoted the survival of the infected cells but they persisted in a G0 state, rather than proliferating. These results argue that bcl-2 provided a distinct survival signal to the cell and may contribute to neoplasia by allowing a clone to persist until other oncogenes, such as c-myc, become activated.

摘要

滤泡性淋巴瘤是人类最常见的血液系统恶性肿瘤,其一个常见特征是染色体易位(t(14;18)),该易位将免疫球蛋白重链基因座与18号染色体上一个名为bcl-2的基因连接在一起。与其他B淋巴细胞肿瘤中易位的c-myc癌基因类似,bcl-2是一个候选癌基因,但尚未有关于bcl-2生物学效应的报道。为了检测bcl-2是否单独或与失调的c-myc基因共同影响造血细胞的生长,我们使用逆转录病毒载体将人bcl-2互补DNA导入正常或Eμ-myc转基因小鼠的骨髓细胞中,在Eμ-myc转基因小鼠中,B系细胞组成性表达c-myc基因。bcl-2与c-myc协同促进B细胞前体的增殖,其中一些前体变成了致瘤性的。为了确定bcl-2表达如何影响对生长因子的需求,将该基因导入需要白细胞介素3(IL-3)的一个淋巴细胞系和一个髓细胞系中。在没有IL-3的情况下,bcl-2促进了被感染细胞的存活,但它们停留在G0状态,而不是增殖。这些结果表明,bcl-2为细胞提供了一个独特的存活信号,并且可能通过允许一个克隆持续存在直到其他癌基因(如c-myc)被激活而促进肿瘤形成。

相似文献

1
Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells.Bcl-2基因可促进造血细胞存活,并与c-myc协同作用使前B细胞永生化。
Nature. 1988 Sep 29;335(6189):440-2. doi: 10.1038/335440a0.
2
Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.myc与bcl-2协同作用在转基因小鼠中诱导产生的新型原始淋巴细胞肿瘤
Nature. 1990 Nov 22;348(6299):331-3. doi: 10.1038/348331a0.
3
The transgenic window on lymphoid malignancy.淋巴系统恶性肿瘤的转基因窗口
Princess Takamatsu Symp. 1989;20:297-309.
4
Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.失调的Bcl-2基因表达选择性地延长了生长因子缺乏的造血细胞系的存活时间。
J Immunol. 1990 May 1;144(9):3602-10.
5
A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis.一种B细胞淋巴瘤的非转基因小鼠模型:Myc逆转录病毒在体内感染p53基因缺失的骨髓祖细胞足以引发肿瘤形成。
Oncogene. 2002 Mar 14;21(12):1922-7. doi: 10.1038/sj.onc.1205244.
6
Bcl-2 confers growth and survival advantage to interleukin 7-dependent early pre-B cells which become factor independent by a multistep process in culture.Bcl-2赋予白介素7依赖的早期前B细胞生长和生存优势,这些细胞在培养过程中通过多步骤过程变得不依赖因子。
Oncogene. 1992 May;7(5):869-76.
7
Insights from transgenic mice regarding the role of bcl-2 in normal and neoplastic lymphoid cells.转基因小鼠对bcl-2在正常和肿瘤性淋巴细胞中作用的见解。
Philos Trans R Soc Lond B Biol Sci. 1994 Aug 30;345(1313):289-95. doi: 10.1098/rstb.1994.0108.
8
Transformation of growth factor-dependent myeloid stem cells with retroviral vectors carrying c-myc.用携带c-myc的逆转录病毒载体转化生长因子依赖性髓系干细胞。
Oncogene. 1989 Jun;4(6):737-51.
9
Survival and death of prelymphomatous B-cells from N-myc/bcl-2 double transgenic mice correlates with the regulation of intracellular Ca2+ fluxes.N-myc/bcl-2双转基因小鼠的前淋巴瘤B细胞的存活与死亡与细胞内Ca2+通量的调节相关。
Oncogene. 1995 Nov 16;11(10):2165-74.
10
Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus.阿贝尔逊鼠白血病病毒和哈维鼠肉瘤病毒对Eμ-myc转基因小鼠骨髓细胞的转化作用
Oncogene Res. 1988 May;2(4):403-9.

引用本文的文献

1
Comprehensive analysis of regulated cell death pathways: intrinsic disorder, protein-protein interactions, and cross-pathway communication.细胞程序性死亡途径的综合分析:内在无序、蛋白质-蛋白质相互作用及跨途径通讯
Apoptosis. 2025 Aug 19. doi: 10.1007/s10495-025-02161-6.
2
Comprehensive view on chemotherapy-free management of acute myeloid leukemia by using venetoclax in combination with targeted and/or immune therapies.关于使用维奈托克联合靶向和/或免疫疗法对急性髓系白血病进行无化疗管理的综合观点。
Cell Death Discov. 2025 Aug 13;11(1):379. doi: 10.1038/s41420-025-02678-4.
3
Molecular Pathways and Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL).
复发/难治性弥漫性大B细胞淋巴瘤(DLBCL)的分子通路与靶向治疗
Cancers (Basel). 2025 Jul 11;17(14):2314. doi: 10.3390/cancers17142314.
4
Comparative transcriptome analysis of bovine blastocysts reveals specific effects of the oocyte source and the environments during maturation and early embryo development.牛囊胚的比较转录组分析揭示了卵母细胞来源以及成熟和早期胚胎发育过程中环境的特定影响。
BMC Genomics. 2025 Jul 17;26(1):673. doi: 10.1186/s12864-025-11848-8.
5
Primary vitreoretinal lymphoma: diagnosis, treatment, and prognosis-a review of current knowledge and future directions.原发性玻璃体视网膜淋巴瘤:诊断、治疗及预后——当前知识与未来方向综述
Blood Sci. 2025 May 1;7(2):e00233. doi: 10.1097/BS9.0000000000000233. eCollection 2025 Jun.
6
Comprehensive Characterization of Bruton's Tyrosine Kinase Inhibitor Specificity, Potency, and Biological Effects: Insights into Covalent and Noncovalent Mechanistic Signatures.布鲁顿酪氨酸激酶抑制剂的特异性、效力及生物学效应的全面表征:对共价和非共价作用机制特征的深入洞察
ACS Pharmacol Transl Sci. 2025 Mar 12;8(4):917-931. doi: 10.1021/acsptsci.4c00540. eCollection 2025 Apr 11.
7
The BCL-2 protein family: from discovery to drug development.BCL-2蛋白家族:从发现到药物研发
Cell Death Differ. 2025 Apr 9. doi: 10.1038/s41418-025-01481-z.
8
Non-canonical functions of BCL-2 family members in energy metabolism and necrotic cell death regulation.BCL-2家族成员在能量代谢和坏死性细胞死亡调控中的非经典功能。
Cell Cycle. 2024 Nov-Dec;23(21-24):931-948. doi: 10.1080/15384101.2025.2484868. Epub 2025 Mar 27.
9
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy.BCL2家族:从细胞凋亡机制到靶向治疗的新进展
Signal Transduct Target Ther. 2025 Mar 21;10(1):91. doi: 10.1038/s41392-025-02176-0.
10
From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders.从机制到医学:铁死亡作为肝脏疾病的治疗靶点
Cell Commun Signal. 2025 Mar 7;23(1):125. doi: 10.1186/s12964-025-02121-2.